Wall Street Jedi
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Wall Street Jedi
No Result
View All Result
Home Investing

Pennsylvania man charged with insider trading related to CVS takeover

by
October 31, 2024
in Investing
0
Pennsylvania man charged with insider trading related to CVS takeover
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

By Jonathan Stempel

(Reuters) – Federal prosecutors charged a Pennsylvania man on Thursday with insider trading for using tips from his domestic partner to trade illegally ahead of CVS Health (NYSE:CVS)’s $9.5 billion purchase last year of primary care provider Oak Street Health.

Carlos Sacanell, 58, of Willow Grove, was also charged with lying to the FBI by denying having received the tips before the takeover was announced in February 2023. The U.S. Securities and Exchange Commission filed a related civil case against Sacanell.

A lawyer for Sacanell did not immediately respond to requests for comment. The office of U.S. Attorney Jacqueline Romero in Philadelphia said Sacanell was arrested on Thursday at his home.

Authorities said Sacanell generated $617,000 trading in Oak Street stock and options after his partner, a senior Oak Street executive, shared material non-public information about the planned takeover.

The SEC said the trading began two days after Sacanell’s partner, who had learned a takeover might be in the offing, lamented in a text message that it was “very uncomfortable having information I can’t share.”

Sacanell texted back that his partner should tell inquiring co-workers you don’t know what’s going on, the SEC said.

The partner was not charged.

CVS, the drugstore chain and pharmacy benefits manager, agreed to buy Oak Street for $39 per share, 50% above where the stock traded shortly before news of the takeover became public, the SEC said.

Oak Street’s share price rose 36% over the next two days, including after CVS announced the takeover. CVS valued the transaction at $10.6 billion including debt.

This post appeared first on investing.com
Previous Post

Earnings call: ASE Technology reports growth and expansion plans in Q3 2024

Next Post

Earnings call: Insperity reports mixed Q3 results, optimistic for 2025

Next Post
Earnings call: Insperity reports mixed Q3 results, optimistic for 2025

Earnings call: Insperity reports mixed Q3 results, optimistic for 2025

  • Trending
  • Comments
  • Latest
American creating deepfakes targeting Harris works with Russian intel, documents show

American creating deepfakes targeting Harris works with Russian intel, documents show

October 23, 2024
Cadence raises midpoint of 2024 profit forecast on robust demand from chip designers

Cadence raises midpoint of 2024 profit forecast on robust demand from chip designers

October 28, 2024
Earnings call: Microsoft sees soaring cloud and AI growth in Q1 FY2025

Earnings call: Microsoft sees soaring cloud and AI growth in Q1 FY2025

October 31, 2024
Israel stocks lower at close of trade; TA 35 down 0.23%

Israel stocks lower at close of trade; TA 35 down 0.23%

October 6, 2024
Essence Fest leads a summer of events for Black entrepreneurs galvanized by economic uncertainty

Essence Fest leads a summer of events for Black entrepreneurs galvanized by economic uncertainty

0
Retailers scramble to move billions in cargo as East Coast dockworkers prepare to strike

Retailers scramble to move billions in cargo as East Coast dockworkers prepare to strike

0
PepsiCo to buy tortilla chip maker Siete Foods for $1.2 billion

PepsiCo to buy tortilla chip maker Siete Foods for $1.2 billion

0
East and Gulf coast ports shut down as thousands of workers go on strike

East and Gulf coast ports shut down as thousands of workers go on strike

0
Essence Fest leads a summer of events for Black entrepreneurs galvanized by economic uncertainty

Essence Fest leads a summer of events for Black entrepreneurs galvanized by economic uncertainty

July 4, 2025
Tariffs and weaker beer demand are weighing on Modelo owner Constellation Brands

Tariffs and weaker beer demand are weighing on Modelo owner Constellation Brands

July 3, 2025
Microsoft laying off about 9,000 employees in latest round of cuts

Microsoft laying off about 9,000 employees in latest round of cuts

July 3, 2025
Apple sues former Vision Pro employee for allegedly stealing ‘thousands of documents’ before joining Snap

Apple sues former Vision Pro employee for allegedly stealing ‘thousands of documents’ before joining Snap

July 2, 2025

Recent News

Essence Fest leads a summer of events for Black entrepreneurs galvanized by economic uncertainty

Essence Fest leads a summer of events for Black entrepreneurs galvanized by economic uncertainty

July 4, 2025
Tariffs and weaker beer demand are weighing on Modelo owner Constellation Brands

Tariffs and weaker beer demand are weighing on Modelo owner Constellation Brands

July 3, 2025
Microsoft laying off about 9,000 employees in latest round of cuts

Microsoft laying off about 9,000 employees in latest round of cuts

July 3, 2025
Apple sues former Vision Pro employee for allegedly stealing ‘thousands of documents’ before joining Snap

Apple sues former Vision Pro employee for allegedly stealing ‘thousands of documents’ before joining Snap

July 2, 2025

Disclaimer: WallStreetJedi.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 wallstreetjedi.com | All Rights Reserved

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 wallstreetjedi.com | All Rights Reserved